BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 27213455)

  • 1. The Roles of NDR Protein Kinases in Hippo Signalling.
    Hergovich A
    Genes (Basel); 2016 May; 7(5):. PubMed ID: 27213455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation and functions of mammalian LATS/NDR kinases: looking beyond canonical Hippo signalling.
    Hergovich A
    Cell Biosci; 2013 Aug; 3(1):32. PubMed ID: 23985307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NDR/LATS protein kinases in immunology and cancer biology.
    Sharif AAD; Hergovich A
    Semin Cancer Biol; 2018 Feb; 48():104-114. PubMed ID: 28579171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downstream of human NDR kinases: impacting on c-myc and p21 protein stability to control cell cycle progression.
    Cornils H; Kohler RS; Hergovich A; Hemmings BA
    Cell Cycle; 2011 Jun; 10(12):1897-904. PubMed ID: 21593588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinases of the Hippo pathway: regulation and substrates.
    Avruch J; Zhou D; Fitamant J; Bardeesy N; Mou F; Barrufet LR
    Semin Cell Dev Biol; 2012 Sep; 23(7):770-84. PubMed ID: 22898666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring the Kinase Activities of the LATS/NDR Protein Kinases.
    Hergovich A
    Methods Mol Biol; 2019; 1893():305-317. PubMed ID: 30565143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NDR/LATS protein kinases in neurobiology: Key regulators of cell proliferation, differentiation and migration in the ocular and central nervous system.
    Santos PF; Fazendeiro B; Luca FC; Ambrósio AF; Léger H
    Eur J Cell Biol; 2023 Jun; 102(2):151333. PubMed ID: 37327741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippo Signaling in Mitosis: An Updated View in Light of the MEN Pathway.
    Hergovich A
    Methods Mol Biol; 2017; 1505():265-277. PubMed ID: 27826870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hippo pathway in disease and therapy: cancer and beyond.
    Gomez M; Gomez V; Hergovich A
    Clin Transl Med; 2014; 3():22. PubMed ID: 25097725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mob Family Proteins: Regulatory Partners in Hippo and Hippo-Like Intracellular Signaling Pathways.
    Duhart JC; Raftery LA
    Front Cell Dev Biol; 2020; 8():161. PubMed ID: 32266255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
    Irie K; Nagai T; Mizuno K
    J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.
    Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL
    Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippo pathway - brief overview of its relevance in cancer.
    Zygulska AL; Krzemieniecki K; Pierzchalski P
    J Physiol Pharmacol; 2017 Jun; 68(3):311-335. PubMed ID: 28820389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monopolar spindle-one-binder protein 2 regulates the activity of large tumor suppressor/yes-associated protein to inhibit the motility of SMMC-7721 hepatocellular carcinoma cells.
    Zhang W; Shen J; Gu F; Zhang Y; Wu W; Weng J; Liao Y; Deng Z; Yuan Q; Zheng L; Zhang Y; Shen W
    Oncol Lett; 2018 Apr; 15(4):5375-5383. PubMed ID: 29552181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling.
    Hergovich A; Hemmings BA
    Biofactors; 2009; 35(4):338-45. PubMed ID: 19484742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hippo Pathway: Biology and Pathophysiology.
    Ma S; Meng Z; Chen R; Guan KL
    Annu Rev Biochem; 2019 Jun; 88():577-604. PubMed ID: 30566373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling.
    Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A
    Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MOB1 Mediated Phospho-recognition in the Core Mammalian Hippo Pathway.
    Couzens AL; Xiong S; Knight JDR; Mao DY; Guettler S; Picaud S; Kurinov I; Filippakopoulos P; Sicheri F; Gingras AC
    Mol Cell Proteomics; 2017 Jun; 16(6):1098-1110. PubMed ID: 28373298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable MOB1 interaction with Hippo/MST is not essential for development and tissue growth control.
    Kulaberoglu Y; Lin K; Holder M; Gai Z; Gomez M; Assefa Shifa B; Mavis M; Hoa L; Sharif AAD; Lujan C; Smith ESJ; Bjedov I; Tapon N; Wu G; Hergovich A
    Nat Commun; 2017 Sep; 8(1):695. PubMed ID: 28947795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of mammalian sterile 20-like kinase 2-dependent phosphorylations of Mps one binder 1B in the activation of nuclear Dbf2-related kinases.
    Bao Y; Sumita K; Kudo T; Withanage K; Nakagawa K; Ikeda M; Ohno K; Wang Y; Hata Y
    Genes Cells; 2009 Dec; 14(12):1369-81. PubMed ID: 19919647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.